Sirolimus-eluting stent at least as effective as CABG

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1484, 2005-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sirolimus-eluting stent superior in diabetes

By  

Inpharma, Vol. 1, Iss. 1461, 2004-01 ,pp. : 9-10

Adis International

Access to resources Recommend Favorite

A polymer-free, sirolimus-eluting stent is as effective as a standard, polymer-based, paclitaxel-eluting stent in the prevention of coronary artery restenosis

By  

Inpharma, Vol. 1, Iss. 1530, 2006-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent superior to balloon angioplasty in restenosis

By  

Inpharma, Vol. 1, Iss. 1544, 2006-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent continues to impress in complex patients

By  

Inpharma, Vol. 1, Iss. 1513, 2005-01 ,pp. : 13-14

Adis International

Access to resources Recommend Favorite

Sirolimus-eluting stent superior: the REALITY hits home

By  

Inpharma, Vol. 1, Iss. 1483, 2005-01 ,pp. : 10-10

Adis International

Access to resources Recommend Favorite